New app could let cystic fibrosis patients skip some clinic visits
NCT ID NCT06147778
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a smartphone app called MuCopilot that helps people with cystic fibrosis measure their lung function and exercise ability at home. 70 adults in France used the app to perform tests like speaking into the phone and timed walks, and researchers compared those results to standard clinic tests. The goal was to see if the app provides reliable data that could reduce the need for frequent hospital visits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHM - Hôpital Nord de Marseille
Marseille, 13015, France
-
American Memorial Hospital
Reims, 51100, France
-
CRCM Mixte - Hôpital Charles Nicolle
Rouen, 76031, France
-
Centre Hospitalier Lyon Sud (Adultes)
Lyon, 69495, France
-
Centre de Perharidy, Fondation Idlys
Roscoff, 29682, France
-
Centre de compétence Maladies pulmonaires rares Hôpital Pasteur CHU de Nice
Nice, 06002, France
-
Hôpital Larrey
Toulouse, 31059, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smartphone tool may help cystic fibrosis patients survive the lung transplant waitlist
- Can a smartphone app reveal how CF treatments really work at home?
- Can a peer coach help young people take control of their chronic illness?
- Could a single antibiotic be enough for cystic fibrosis lung infections?
- Early use of powerful CF drugs may boost growth in young children
- Hands-On therapy may soothe cystic fibrosis pain without drugs